294 related articles for article (PubMed ID: 17360571)
1. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections.
Zhang L; Yan K; Zhang Y; Huang R; Bian J; Zheng C; Sun H; Chen Z; Sun N; An R; Min F; Zhao W; Zhuo Y; You J; Song Y; Yu Z; Liu Z; Yang K; Gao H; Dai H; Zhang X; Wang J; Fu C; Pei G; Liu J; Zhang S; Goodfellow M; Jiang Y; Kuai J; Zhou G; Chen X
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4606-11. PubMed ID: 17360571
[TBL] [Abstract][Full Text] [Related]
2. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
[TBL] [Abstract][Full Text] [Related]
3. Small molecules restore azole activity against drug-tolerant and drug-resistant
Alabi PE; Gautier C; Murphy TP; Gu X; Lepas M; Aimanianda V; Sello JK; Ene IV
mBio; 2023 Aug; 14(4):e0047923. PubMed ID: 37326546
[TBL] [Abstract][Full Text] [Related]
4. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y
J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711
[TBL] [Abstract][Full Text] [Related]
5. The synergistic antifungal activity of resveratrol with azoles against Candida albicans.
Wang J; Zhang X; Gao L; Wang L; Song F; Zhang L; Wan Y
Lett Appl Microbiol; 2021 Jun; 72(6):688-697. PubMed ID: 33550599
[TBL] [Abstract][Full Text] [Related]
6. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
[TBL] [Abstract][Full Text] [Related]
7. Oxythiamine improves antifungal activity of ketoconazole evaluated in canine Malassezia pachydermatis strains.
Siemieniuk M; Sosnowska K; Czerniecki J; Czyzewska U; Winnicka K; Tylicki A
Vet Dermatol; 2018 Dec; 29(6):476-e160. PubMed ID: 30251451
[TBL] [Abstract][Full Text] [Related]
8. Posaconazole: a new broad-spectrum antifungal agent.
Kwon DS; Mylonakis E
Expert Opin Pharmacother; 2007 Jun; 8(8):1167-78. PubMed ID: 17516880
[TBL] [Abstract][Full Text] [Related]
9. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
10. Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
Choi JW; Lee KT; Kim S; Lee YR; Kim HJ; Seo KJ; Lee MH; Yeon SK; Jang BK; Park SJ; Kim HJ; Park JH; Kim D; Lee DG; Cheong E; Lee JS; Bahn YS; Park KD
J Med Chem; 2021 Nov; 64(21):15912-15935. PubMed ID: 34662122
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.
Wong SS; Kao RY; Yuen KY; Wang Y; Yang D; Samaranayake LP; Seneviratne CJ
PLoS One; 2014; 9(1):e85836. PubMed ID: 24465737
[TBL] [Abstract][Full Text] [Related]
12. Beauvericin counteracted multi-drug resistant
Tong Y; Liu M; Zhang Y; Liu X; Huang R; Song F; Dai H; Ren B; Sun N; Pei G; Bian J; Jia XM; Huang G; Zhou X; Li S; Zhang B; Fukuda T; Tomoda H; Ōmura S; Cannon RD; Calderone R; Zhang L
Synth Syst Biotechnol; 2016 Sep; 1(3):158-168. PubMed ID: 29062940
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
14. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
[TBL] [Abstract][Full Text] [Related]
15. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
16. Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.
Wambaugh MA; Denham ST; Ayala M; Brammer B; Stonhill MA; Brown JC
Elife; 2020 May; 9():. PubMed ID: 32367801
[TBL] [Abstract][Full Text] [Related]
17. Strategies in the discovery of novel antifungal scaffolds.
Liu N; Wang C; Su H; Zhang W; Sheng C
Future Med Chem; 2016 Aug; 8(12):1435-54. PubMed ID: 27463376
[TBL] [Abstract][Full Text] [Related]
18. Antifungal combinations.
Vitale RG; Afeltra J; Dannaoui E
Methods Mol Med; 2005; 118():143-52. PubMed ID: 15888940
[TBL] [Abstract][Full Text] [Related]
19. Semisynthesis and Biological Evaluation of Xanthone Amphiphilics as Selective, Highly Potent Antifungal Agents to Combat Fungal Resistance.
Lin S; Sin WLW; Koh JJ; Lim F; Wang L; Cao D; Beuerman RW; Ren L; Liu S
J Med Chem; 2017 Dec; 60(24):10135-10150. PubMed ID: 29155590
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial strategies for combating invasive fungal infections.
Spitzer M; Robbins N; Wright GD
Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
